Frederick B. Oleson

1.5k citations
26 papers · 1.2k indexed · h-index 16

Frederick B. Oleson

25 papers receiving 1.1k citations

Peers

Frederick B. Oleson
Comparison fields: 5 of 104
  • Chemical Health and Safety 25
  • Clinical Biochemistry 173
  • Infectious Diseases 406
  • Molecular Medicine 94
  • Cancer Research 253
Replace Jon C. Mirsalis with:
Jon C. Mirsalis United States
YASUHIRO MINE Japan
Daniel M. Wilson United States
Roger L. Van Tassell United States
Henry S. Heine United States
C.E. Voogd Netherlands
Kunihiko Fukuchi Japan
Isamu Matsunaga Japan
Sarah Mollerup Denmark
D. Beyer Germany
Frederick B. Oleson relative to Jon C. Mirsalis United States Jon C. Mirsalis's profile →
Citations per field
00.5×4.9×
Jon C. Mirsalis · 1×
Citations per year

Countries citing papers authored by Frederick B. Oleson

Since Specialization
Citations

This map shows the geographic impact of Frederick B. Oleson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick B. Oleson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick B. Oleson more than expected).

Fields of papers citing papers by Frederick B. Oleson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick B. Oleson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick B. Oleson. The network helps show where Frederick B. Oleson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Frederick B. Oleson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frederick B. Oleson Line = papers co-authored together Frederick B. Oleson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20238
2 20147
3 201418
4 20109
5 2010106
6 201015
7 200821
8 200431
9 2000158
10 199762
11 199426
12 1994278
13 199310
14 19931
15 19924
16 19919
17 199163
18 198840
19 197710
20 197239

About Frederick B. Oleson

Frederick B. Oleson is a scholar working on Physiology, Cancer Research and Clinical Biochemistry, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (6 papers), Antimicrobial Resistance in Staphylococcus (4 papers), DNA Repair Mechanisms (2 papers), Mitochondrial Function and Pathology (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Orthopedic Infections and Treatments (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). The work is most often cited by research in Chemical Health and Safety (25 citations), Clinical Biochemistry (173 citations) and Infectious Diseases (406 citations). Frederick B. Oleson has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Carol W. Berman, Francis P. Tally, Barry I. Eisenstein, Richard H. Baltz, James T. MacGregor, Jan‐Ji Lai, Jeannie B. Kirkpatrick, Karen Regan, Claudio Carini and George L. Drusano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026